The radiopharmaceutical market size was valued at USD 3.3 billion in 2021 and is projected to grow from USD 3.5 billion in 2022 to USD 5.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period (2023 - 2032).
The radiopharmaceutical market continues to expand globally, driven by increasing applications in nuclear medicine, diagnostics, and...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian